Red clover extract exerts antidiabetic and hypolipidemic effects in db/db mice

Qiu,Longxin; Chen,Tong; Zhong,Fojin; Hong,Yamin; Chen,Limei; Ye,Hong

doi:10.3892/etm.2012.658

Red clover extract exerts antidiabetic and hypolipidemic effects in db/db mice

Authors:
- Longxin Qiu
- Tong Chen
- Fojin Zhong
- Yamin Hong
- Limei Chen
- Hong Ye
View Affiliations

Affiliations: School of Life Sciences, Longyan University, Longyan 364000, P.R. China, Fujian Key Laboratory of Preventive Veterinary Medicine and Biotechnology, Longyan University, Longyan 364000, P.R. China
Published online on: August 9, 2012 https://doi.org/10.3892/etm.2012.658
Pages: 699-704

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

To investigate the effects of red clover extract on the blood glucose and lipid levels of type 2 diabetic db/db mice, male db/db mice were treated with this extract for a period of 5 weeks. The red clover extract had a significant effect on lowering the blood glucose levels of db/db mice. The serum triglyceride, serum total cholesterol, liver triglyceride and liver cholesterol levels for diabetic mice receiving red clover extract were significantly lower compared to those of the untreated diabetic mice. The mRNA expression of two target genes transcriptionally regulated by peroxisome proliferator-activated receptor (PPAR)γ was determined by quantitative real-time RT-PCR, and red clover extract was observed to significantly upregulate hepatic glucokinase and CD36 expression. Four target genes transcriptionally regulated by PPARα were also assayed, and red clover extract was observed to significantly downregulate hepatic apolipoprotein C3 expression whereas it had no significant effect on apolipoprotein A5, acetyl CoA oxidase and carnitine palmitoyl transferase-1 expression. In addition, hepatic mRNA expression of fatty acid synthase was also observed to be downregulated by red clover extract treatment. Thus, we conclude that red clover extract significantly improves the glucose and lipid homeostasis in db/db diabetic mice and that these effects are achieved at least in part by activating hepatic PPARα/γ and by inhibiting hepatic fatty acid synthase.

View Figures

View References

1	Wong MC, Emery PW, Preedy VR and Wiseman H: Health benefits of isoflavones in functional foods? Proteomic and meta-bonomic advances. Inflammopharmacology. 16:235–239. 2008. View Article : Google Scholar : PubMed/NCBI
2	Usui T: Pharmaceutical prospects of phytoestrogens. Endocr J. 53:7–20. 2006. View Article : Google Scholar : PubMed/NCBI
3	Bhathena SJ and Velasquez MT: Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr. 76:1191–1201. 2002.PubMed/NCBI
4	Lee JS: Effects of soy protein and genistein on blood glucose, antioxidant enzyme activities, and lipid profile in streptozotocin-induced diabetic rats. Life Sci. 79:1578–1584. 2006. View Article : Google Scholar : PubMed/NCBI
5	Mezei O, Banz WJ, Steger RW, Peluso MR, Winters TA and Shay N: Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells. J Nutr. 133:1238–1243. 2003.PubMed/NCBI
6	Jayagopal V, Albertazzi P, Kilpatrick ES, et al: Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Diabetes Care. 25:1709–1714. 2002. View Article : Google Scholar : PubMed/NCBI
7	Li Z, Hong K, Saltsman P, et al: Long-term efficacy of soy-based meal replacements vs an individualized diet plan in obese type II DM patients: relative effects on weight loss, metabolic parameters, and C-reactive protein. Eur J Clin Nutr. 59:411–418. 2005. View Article : Google Scholar : PubMed/NCBI
8	Gobert CP, Pipe EA, Capes SE, Darlington GA, Lampe JW and Duncan AM: Soya protein does not affect glycaemic control in adults with type 2 diabetes. Br J Nutr. 103:412–421. 2009. View Article : Google Scholar : PubMed/NCBI
9	González S, Jayagopal V, Kilpatrick ES, Chapman T and Atkin SL: Effects of isoflavone dietary supplementation on cardiovascular risk factors in type 2 diabetes. Diabetes Care. 30:1871–1873. 2007.PubMed/NCBI
10	Qiu L, Ye H, Chen L, Hong Y, Zhong F and Zhang T: Red clover extract ameliorates dyslipidemia in streptozotocin-induced diabetic C57BL/6 mice by activating hepatic PPARα. Phytother Res. 26:860–864. 2012.PubMed/NCBI
11	Kota BP, Huang TH and Roufogalis BD: An overview on biological mechanisms of PPARs. Pharmacol Res. 51:85–94. 2005. View Article : Google Scholar : PubMed/NCBI
12	Shen P, Liu MH, Ng TY, Chan YH and Yong EL: Differential effects of isoflavones, from Astragalus membranaceus and Pueraria thomsonii, on the activation of PPARalpha, PPARgamma, and adipocyte differentiation in vitro. J Nutr. 136:899–905. 2006.PubMed/NCBI
13	Inoue M, Ohtake T, Motomura W, et al: Increased expression of PPARgamma in high fat diet-induced liver steatosis in mice. Biochem Biophys Res Commun. 336:215–222. 2005. View Article : Google Scholar : PubMed/NCBI
14	Kim SY, Kim HI, Park SK, et al: Liver glucokinase can be activated by peroxisome proliferator-activated receptor-gamma. Diabetes. 53(Suppl 1): S66–S70. 2004. View Article : Google Scholar : PubMed/NCBI
15	Mueller M, Hobiger S and Jungbauer A: Red clover extract: a source for substances that activate peroxisome proliferator-activated receptor alpha and ameliorate the cytokine secretion profile of lipopolysaccharide-stimulated macrophages. Menopause. 17:379–387. 2010.
16	Qiu L, Lin B, Lin Z, Lin Y, Lin M and Yang X: Biochanin A ameliorates the cytokine secretion profile of lipopolysaccharide-stimulated macrophages by a PPARγ-dependent pathway. Mol Med Report. 5:217–222. 2012.PubMed/NCBI
17	Guo L and Tabrizchi R: Peroxisome proliferator-activated receptor gamma as a drug target in the pathogenesis of insulin resistance. Pharmacol Ther. 111:145–173. 2006. View Article : Google Scholar : PubMed/NCBI
18	Ronis MJ, Chen Y, Badeaux J and Badger TM: Dietary soy protein isolate attenuates metabolic syndrome in rats via effects on PPAR, LXR, and SREBP signaling. J Nutr. 139:1431–1438. 2009. View Article : Google Scholar : PubMed/NCBI
19	Asgary S, Moshtaghian J, Naderi G, et al: Effects of dietary red clover on blood factors and cardiovascular fatty streak formation in hypercholesterolemic rabbits. Phytother Res. 21:768–770. 2007. View Article : Google Scholar : PubMed/NCBI
20	Geller SE and Studee L: Soy and red clover for mid-life and aging. Climacteric. 9:245–263. 2006. View Article : Google Scholar : PubMed/NCBI
21	Lukaczer D, Darland G, Tripp M, et al: Clinical effects of a proprietary combination isoflavone nutritional supplement in menopausal women: a pilot trial. Altern Ther Health Med. 11:60–65. 2005.PubMed/NCBI
22	Schult TM, Ensrud KE, Blackwell T, Ettinger B, Wallace R and Tice JA: Effect of isoflavones on lipids and bone turnover markers in menopausal women. Maturitas. 48:209–218. 2004. View Article : Google Scholar : PubMed/NCBI
23	Haines C, James A, Sahota D, et al: Comparison between phytoestrogens and estradiol in the prevention of atheroma in ovariectomized cholesterol-fed rabbits. Climacteric. 9:430–436. 2006. View Article : Google Scholar : PubMed/NCBI
24	Howes JB, Sullivan D, Lai N, et al: The effects of dietary supplementation with isoflavones from red clover on the lipoprotein profiles of post menopausal women with mild to moderate hypercholesterolaemia. Atherosclerosis. 152:143–147. 2000. View Article : Google Scholar
25	Lefebvre P, Chinetti G, Fruchart JC and Staels B: Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. J Clin Invest. 116:571–580. 2006. View Article : Google Scholar : PubMed/NCBI
26	Auwerx J, Schoonjans K, Fruchart JC and Staels B: Transcriptional control of triglyceride metabolism: fibrates and fatty acids change the expression of the LPL and apo C-III genes by activating the nuclear receptor PPAR. Atherosclerosis. 124(Suppl): S29–S37. 1996. View Article : Google Scholar
27	Vu-Dac N, Gervois P, Jakel H, et al: Apolipoprotein A5, a crucial determinant of plasma triglyceride levels, is highly responsive to peroxisome proliferator-activated receptor alpha activators. J Biol Chem. 278:17982–17985. 2003. View Article : Google Scholar
28	Qiu L, Wu X, Chau JF, et al: Aldose reductase regulates hepatic peroxisome proliferator-activated receptor alpha phosphorylation and activity to impact lipid homeostasis. J Biol Chem. 283:17175–17183. 2008. View Article : Google Scholar
29	Semenkovich CF: Regulation of fatty acid synthase (FAS). Prog Lipid Res. 36:43–53. 1997. View Article : Google Scholar : PubMed/NCBI
30	Horton JD and Shimomura I: Sterol regulatory element-binding proteins: activators of cholesterol and fatty acid biosynthesis. Curr Opin Lipidol. 10:143–150. 1999. View Article : Google Scholar : PubMed/NCBI
31	Horton JD, Goldstein JL and Brown MS: SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest. 109:1125–1131. 2002. View Article : Google Scholar : PubMed/NCBI
32	Shin ES, Lee HH, Cho SY, Park HW, Lee SJ and Lee TR: Genistein downregulates SREBP-1 regulated gene expression by inhibiting site-1 protease expression in HepG2 cells. J Nutr. 137:1127–1131. 2007.PubMed/NCBI